(AIM: SAR)

9 March 2017

SAREUM HOLDINGS PLC

(“Sareum” or “the Company”)

Director shareholding

Sareum announces that Dr. Stephen Parker, Sareum’s Chairman, and his wife purchased 461,949 and 674,272 shares at 0.95p each respectively yesterday. These are the only shares that Dr Parker or his wife own in the Company. Dr Parker’s shareholding represents 0.017% of the Company’s issued share capital and Dr Parker’s wife’s shareholding represents 0.025% of the Company’s issued share capital.

For further information, please contact:

Sareum Holdings plc

 

Tim Mitchell

01223 497 700

WH Ireland Limited (Nominated Adviser and Co-Broker)

Chris Fielding / Nick Prowting

020 7220 1666

Hybridan LLP (Co-Broker)

 

Claire Noyce / William Lynne

020 3764 2341/2342

The Communications Portfolio (Sareum Media enquiries)

 

Ariane Comstive
Ariane.comstive@communications-portfolio.co.uk 

07785 922 354

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. Stephen Parker

2

Reason for the notification

a)

Position/status

Chairman, Sareum Holdings plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sareum Holdings plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.025p each

 

 

GB00B02RFS12

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.95p

Dr. Stephen Parker: 461,949 shares

Susan Parker: 674,272 shares

Total: 1,136,221 shares

 

d)

Aggregated information

-        Aggregated volume

-        Price

 

1,136,221
0.95p

e)

Date of the transaction

8 March 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

  • @Sareumplc Latest tweet

    RT @sierraoncology: Sierra sponsors the DNA Damage Response Therapeutics Summit next week in Boston. On Jan 30, CSO Dr. Chris Hassig will p… via @Sareumplc
    View more